1,4-(diphenlyalkyl) piperazine derivatives
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 7, 1998
Grant Date -
N/A
app pub date -
Mar 25, 1996
filing date -
Jul 28, 1993
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
This invention relates to novel compounds of the formula ?I!, ##STR1## wherein R.sup.1 and R.sup.2 are the same or different and each represents a lower alkoxy group; A and B are the same or different and each represents a lower alkylene group. The compounds of this invention have affinities for sigma receptors and are useful for therapeutic agents for cerebral neural function disorders such as dementia, depression, schizophrenia and anxiety neurosis, diseases accompanying abnormal immune response and cryptorrhea, digestive ulcer, etc.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully